March 06, 2007
Account wins from the 03/06/07 news brief
Natrel Communications has been chosen by Oscient Pharmaceuticals as agency of record for Antara (fenofibrate capsules). Antara is indicated to reduce elevated LDL-C, total-C, triglycerides, and apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia and for treatment of adult patients with hypertriglyceridemia. Oscient Pharmaceuticals is based in Waltham, MA.